- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05989685
Psychometric Validation of the Camouflaging Autistic Traits Questionnaire (CAT-Q/DE)
Psychometric Validation of the Camouflaging Autistic Traits Questionnaire (CAT-Q/DE) in a German Population of Autistic and Non-autistic Adolescents.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Johannes Boettcher, Dr.
- Phone Number: +49 040 7410-52202
- Email: j.boettcher@uke.de
Study Locations
-
-
-
Hamburg, Germany, 20251
- Recruiting
- University Medical Center Hamburg-Eppendorf
-
Contact:
- Johannes Boettcher, Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria study group:
- patients who meet the principal diagnosis of ASD, which includes atypical autism (ICD-10: F84.1) and Asperger syndrome (ICD-10: F84.5), and are between the ages of 13 and 21 years old.
Exclusion Criteria study group:
- Dementia / below average cognitive abilities (IQ < 85)
- lack of German language skills
- severe visual or hearing impairment (uncorrected)
Inclusion Criteria control group:
- Adolescents who do not have a lifetime principal diagnosis of a psychiatric disorder (ICD-10-GM-2016: F10 - F69) and are between 13 and 21 years old.
Exclusion Criteria Control Group:
- dementia / below average general cognitive ability (IQ < 85)
- lack of German language skills
- severe impairment of vision or hearing (not corrected).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Study group
Adolescents between the ages of 13-21 who meet diagnostic criteria for an autism spectrum disorder.
|
|
Control group
Adolescents aged 13-21 years without a lifetime psychiatric diagnosis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Camouflaging
Time Frame: 3-4 minutes
|
Camouflaging Autistic Traits Questionnaire (CAT-Q; Hull et al., 2019) is a quantitative measure of camouflaging.
The CAT-Q can be used as a self-report and parent report version.
The CAT-Q was constructed to be appropriate for both autistic and non-autistic populations (Hull et al., 2019).
The instrument includes 25 items that are answered on a seven-point Likert scale.
|
3-4 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Autistic Traits
Time Frame: 3 minutes
|
The Social Responsiveness Scale (SRS-16; Constantino et al., 2003) is a quantitative measure of autistic traits in children, adolescents, and adults.
The SRS-16 (Sturm et al., 2017) is a 16-item parent questionnaire assessing social, communicative, and rigid behaviors in children and adolescents in terms of a dimensional diagnosis of autism.
|
3 minutes
|
|
Mental health
Time Frame: 4 minutes
|
The Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997) is one of the most frequently used methods for assessing mental health in children and adolescents from a self- and parent perspective.
In addition to the version for children and adolescents, there is also a version for adults, the SDQ 18+.
The SDQ assesses mental health problems and resources of children and adolescents with 5 items each on five subscales: behavioral problems, emotional problems, hyperactivity, peer problems, and prosocial behavior.
It has good psychometric properties, is economical, and has been widely used in research (Goodman, 2001).
|
4 minutes
|
|
Mentalizing
Time Frame: 1 minute
|
The Reflective Function Questionnaire for Youth-5 (RFQ-Y; Sharp et al., 2022) measures mentalizing ability in adolescents.
The English version showed satisfactory psychometric properties (Sharp et al., 2022).
|
1 minute
|
|
Theory of Mind
Time Frame: 3-4 minutes
|
The Frith-Happé Animations Test (Livingston et al., 2021), which represents interactions between triangles in animations, is an online instrument for measuring Theory of Mind (ToM).
The web-based version of this test provides a quick and objective measurement of the construct ToM using multiple-choice questions.
The instrument demonstrated good psychometric properties in a clinical as well as a non-clinical sample (Livingston et al., 2021).
|
3-4 minutes
|
|
Symptoms of depression
Time Frame: 1 minutes
|
The Patient Health Questionnaire scale 9 (PHQ-9; (Kroenke et al., 2001), is a self-report questionnaire designed to assess the severity of depressive disorder in adolescents and adults.
The PHQ-9 has been shown to display good psychometric properties and has been validated in autistic adolescents and adults (Arnold et al., 2020).
|
1 minutes
|
|
Symptoms of anxiety
Time Frame: 1 minutes
|
The Generalized Anxiety Disorder scale 7 (GAD-7; Spitzer et al., 2006), is a self-report questionnaire designed to assess the severity of anxiety in adolescents and adults.
The GAD-7 has been validated in adolescent and adult populations, displaying good psychometric properties (Löwe et al., 2008).
The GAD-7 is strongly correlated with anxiety measures including the Beck Anxiety Inventory (Spitzer et al., 2006) and provides a valid measure also of other anxiety disorders, e.g.
social anxiety and panic disorder (Kroenke et al., 2007).
|
1 minutes
|
|
Stress
Time Frame: 1 minutes
|
The Perceived Stress Scale (PSS-10; Schneider et al., 2020) is a 10-item questionnaire commonly used to assess stress levels in adolescents and adults 12 years and older.
It assesses the extent to which a person has perceived life as unpredictable, uncontrollable, and overwhelming in the past month.
|
1 minutes
|
|
Loneliness
Time Frame: 1 minute
|
3-item Loneliness Scale (Klein et al., 2021): Loneliness is also measured by the 3-item Loneliness Scale.
The scale is an economic measure derived from the R-UCLA Loneliness Scale (Russell et al., 1980) that captures basic aspects of loneliness: A sense of isolation, disconnectedness, and not belonging.
Items are rated on 5-point Likert scales.
Responses are summed for a total score ranging from 0 to 12, with higher scores indicating higher levels of loneliness.
Autism related adaptations of the instrument was made according to recent research (Grace et al., 2023).
|
1 minute
|
|
Emotion Regulation
Time Frame: 1 minute
|
The Difficulties in Emotion Regulation Scale (DERS; Gratz and Roemer, 2004) was used to measure difficulties in emotion regulation.
Although there are different versions, this study we will use the short version with 8 items as suggested by Penner & Sharp, 2022.
The DERS-8 has shown good psychometric properties (Penner & Sharp, 2022).
|
1 minute
|
|
Parent-Adolescent Communication
Time Frame: 2-3 minutes
|
The quality of dyadic Parent-Adolescent Communication was assessed with the German translation of the Parent-Adolescent Communication Scale (PACS; Barnes & Olson, 1982).
The original measure consists of an adolescent and a parent version with 20 identical items that are rated on a scale from 1 ("strongly disagree") to 5 ("strongly agree").
The German version of the instrument has shown acceptable psychometric properties (Zapf & Boettcher, 2024)
|
2-3 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Johannes Boettcher, Dr., Universitätsklinikum Hamburg-Eppendorf
- Study Chair: Sarah Hohmann, Prof. Dr., Universitätsklinikum Hamburg-Eppendorf
- Study Chair: Carola Bindt, Dr., Universitätsklinikum Hamburg-Eppendorf
- Study Chair: Benno Schimmelmann, Prof. Dr., Universitäre Psychiatrische Dienste Bern
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LPEK-0659
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityCalifornia Department of Developmental ServicesActive, not recruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States